Agios Pharmaceuticals, Inc. (AGIO) NASDAQ
27.62
-0.515(-1.83%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
27.62
-0.515(-1.83%)
Currency In USD
Address
88 Sidney Street
Cambridge, MA 02139-4169
United States of America (the)
Phone
617 649 8600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
486
First IPO Date
July 24, 2013
| Name | Title | Pay | Year Born |
| Brian Goff | Chief Executive Officer & Director | 1.55M | 1969 |
| Craig Thompson | Co-Founder | 50,000 | 1953 |
| Lewis Clayton Cantley | Co-Founder | 50,000 | 1949 |
| Shin-San Su | Co-Founder | 50,000 | 1956 |
| Tak Wah Mak | Co-Founder | 50,000 | 1946 |
| Cecilia Jones | Chief Financial Officer | 802,574 | 1975 |
| James William Burns | Corporate Secretary & Chief Legal Officer | 815,732 | 1978 |
| Tsveta Milanova | Chief Commercial Officer | 836,643 | 1977 |
| Sarah Gheuens | Chief Medical Officer and Head of Research & Development | 927,572 | 1980 |
| T. J. Washburn | VP, Controller & Principal Accounting Officer | 0 | 1982 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.